
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:format>application/pdf</dc:format>
  <dc:format>863153 bytes</dc:format>
  <dc:source>Rheumatology International 39(3)</dc:source>
  <dc:subject xml:lang="eng">Keywords: Catalase · CAT-262C/T polymorphism · Etanercept · Juvenile idiopathic arthritis</dc:subject>
  <dc:description xml:lang="eng">Abstract: Oxidative stress is believed to be of great importance
for both the etiology and the persistence of juvenile
idiopathic arthritis (JIA). The aim of this study was to
investigate the association of -262C/T polymorphism
of the catalase (CAT) gene with JIA, as well as to
evaluate whether this polymorphism can inﬂuence
plasma CAT activity and outcome in JIA patients
treated with etanercept. A total of 154 subjects (60
JIA patients and 94 healthy volunteers) were screened
for CAT-262C/T gene polymorphism using the
polymerase chain reaction–restriction fragment
length polymorphism (PCR–RFLP) method. Plasma
CAT activity was determined using the
spectrophotometric method according to Goth, prior
to and 12 months after anti-TNF (etanercept) therapy.
Clinical outcome was assessed using the JIA ACR
(American College of Rheumatology) response
criteria. The genotype and allele frequency
distributions of CAT-262C/T polymorphism in the
patients were signifcantly
diﬀerent from those of the controls (p = 0.014, p =
0.006). The TT genotype (polymorphic homozygous)
was associated with a 4.36-fold higher likelihood of

Državni univerzitet u Novom Pazaru

having JIA (95% CI 1.545–12.323, p = 0.005) as
compared to the CC genotype (wildtype). At month 12
of treatment, JIA patients, carriers of the CC
genotype, showed signifcantly higher plasma CAT
activity
(p = 0.004) and achieved the JIA ACR 70 response
more often (p= 0.003) than the patients, carriers of
the CT/TT genotype. This is the frst study implying the
possible association of CAT-262C/T polymorphism
with JIA. The results suggest the potential protective
eﬀect of the CC genotype, with regard to CAT activity
and treatment outcome.</dc:description>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:29706</dc:identifier>
  <dc:identifier>doi:10.1007/s00296-019-04246-3</dc:identifier>
  <dc:identifier>cobiss:512133044</dc:identifier>
  <dc:identifier>ISSN: 0172-8172</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:title xml:lang="eng">The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis</dc:title>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:date>2019</dc:date>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:creator id="https://orcid.org/0000-0002-9221-561X">Bašić, Jelena</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-6701-3370">Vojinović, Jelena</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-0600-5411">Jevtović-Stoimenov, Tatjana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-7436-3398">Despotović, Milena</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-7759-9344">Cvetković, Tatjana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-4991-831X">Lazarević, Dragana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-4991-831X">Sušić, Gordana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-8200-2859">Milošević, Vuk</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-2434-8277">Cvetković, Mina</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-1604-8853">Pavlović, Dušica</dc:creator>
</oai_dc:dc>
